| Filed On | Filing |
|---|---|
| 13 Oct 2026 |
Form 4: Inglis Tiffany Eul Davis, Chief Medical Officer
Sold 8,024 shares ($16.3K) |
| 11 Sep 2026 |
Form 4: Inglis Tiffany Eul Davis, Chief Medical Officer
Sold 486 shares ($972) |
| 11 Sep 2026 |
Form 4: Anderson Dyaarl Lee Jr., Chief Commercial Officer
Sold 1,800 shares ($3.6K) |
| 11 Sep 2026 |
Form 4: Lindgardt Zhenya, Director
Sold 7,022 shares ($14K) |
| 11 Sep 2026 |
Form 4: Jackson Benjamin, General Counsel
Sold 2,190 shares ($4.38K) |
| 09 Sep 2026 |
Form 4: Lindgardt Zhenya, Director
Sold 20,139 shares ($40.3K) |
| 02 Sep 2026 | Form 4: Aerts Austin, Chief Financial Officer |
| 01 Sep 2026 |
Form 4: Gleason Scott, Chief Financial Officer
Received 117,924 shares as a grant or award · Granted 169,624 Stock Option (right to buy) |
| 14 Jul 2026 |
Form 4: Phillips Joshua, Director
Received 24,686 shares as a grant or award · Granted 37,971 Stock Option (right to buy) |
| 14 Jul 2026 |
Form 4: Mirza Mansoor Raza, Director
Received 24,197 shares as a grant or award · Granted 37,219 Stock Option (right to buy) |
| 14 Jul 2026 |
Form 4: Lawrence Sandra Aj, Director
Received 24,702 shares as a grant or award · Granted 37,995 Stock Option (right to buy) |
| 14 Jul 2026 |
Form 4: Kamdar Kim P., Director
Received 25,847 shares as a grant or award · Granted 39,757 Stock Option (right to buy) |
| 14 Jul 2026 |
Form 4: Critchfield Gregory C, Director
Received 24,020 shares as a grant or award · Granted 36,946 Stock Option (right to buy) |
| 14 Jul 2026 |
Form 4: Capone Mark Christopher, Director
Received 44,379 shares as a grant or award · Granted 65,803 Stock Option (right to buy) |
| 14 Jul 2026 |
Form 4: Barlow Jane F, Director
Received 24,375 shares as a grant or award · Granted 37,492 Stock Option (right to buy) |
| 15 Jun 2026 |
Form 4: Anderson Dyaarl Lee Jr., Chief Commercial Officer
Sold 4,739 shares ($9.53K) |
| 15 Jun 2026 |
Form 4: Aerts Austin, Chief Financial Officer
Sold 2,037 shares ($4.09K) |
| 15 Jun 2026 |
Form 4: Lindgardt Zhenya, Director
Sold 6,990 shares ($14K) |
| 15 Jun 2026 |
Form 4: Inglis Tiffany Eul Davis, Chief Medical Officer
Sold 362 shares ($728) |
| 15 Jun 2026 |
Form 4: Jackson Benjamin, General Counsel
Sold 2,179 shares ($4.38K) |
Loading...